2 studies scored seven, indicating medium-quality studies with low risk of bias
The safety results in children under 3 years was similar to the therapys known safety profile
Tirzepatide alone produces significant weight lossclinical trials show average reductions of 20-22% body weight over 68 weeksmaking additional lipotropic support potentially unnecessary for many patients
Erythromycin has been shown to be of benefit in enhancing gastric emptying in patients taking GLP1RAs
Punicalagin is the key pomegranate polyphenol inhibiting gut microbial trimethylamine (TMA) production from L-carnitine in an in vitro human colon model
Ma, G., Pan, B., Chen, Y., Guo, C., Zhao, M., Zheng, L., & Chen, B